Which Tests Show Gastric Cancer Risk in a Check-Up?

Gastric cancer is one of the diseases that can progress without symptoms in the early stage. For this reason, evaluating stomach health during the check-up process is important, especially for people in risk groups. To understand gastric cancer risk, looking only at blood tests is not sufficient. The person’s complaints, family history, eating habits, presence of H. pylori, changes in the gastric mucosa, and endoscopic examination when necessary should be evaluated together.

Tests performed during the check-up process do not provide the result of “there is gastric cancer” on their own. The main aim is to detect findings that may create risk for gastric cancer, precancerous changes, or symptoms that require further examination early. Therefore, gastric cancer risk assessment should be addressed together with laboratory tests, stool tests, imaging methods, endoscopy, and specialist physician interpretation.

Why Is Gastric Cancer Risk Assessment Not Done Only With a Blood Test?

Gastric cancer risk is not a condition that can be definitively evaluated with a single blood test. Blood tests can provide information about the person’s general health status, anemia, infection, inflammation, liver and kidney functions. However, they do not directly show cellular changes, ulcers, polyps, atrophic gastritis, or suspicious lesions on the inner surface of the stomach.

For this reason, evaluation of the gastric mucosa is important to understand gastric cancer risk. The gastric mucosa is the tissue that covers the inner surface of the stomach. Precancerous changes often begin in this tissue. Endoscopy comes to the forefront in order to directly see these changes and, if necessary, examine them by taking a sample.

Blood tests play a supportive role in the check-up process. For example, iron deficiency anemia, unexplained weight loss, low B12 level, or suspicion of occult bleeding may require further evaluation in terms of the stomach and digestive system. However, these findings alone do not diagnose gastric cancer; they may only indicate the need for more detailed examination.

One of the Most Important Tests in Gastric Cancer Risk Is Endoscopy

One of the most important methods in gastric cancer risk assessment is upper gastrointestinal system endoscopy. This procedure, also known as gastroscopy, allows the esophagus, stomach, and duodenum to be examined with the help of a camera. Thanks to endoscopy, the gastric mucosa can be seen directly and biopsies can be taken from suspicious areas.

The most important advantage of endoscopy is that it not only provides imaging but also allows tissue samples to be taken. Because although some gastric changes can be seen visually, pathological examination is required for definitive evaluation. With the biopsy result, clearer information can be obtained in terms of gastritis, H. pylori infection, atrophy, intestinal metaplasia, dysplasia, or cancer.

Routine endoscopy is not necessary for every person who has a check-up. The decision for endoscopy is made according to age, complaints, family history, H. pylori status, previous stomach diseases, and the physician’s evaluation. Especially if there are findings such as long-lasting stomach pain, indigestion, difficulty swallowing, unexplained weight loss, anemia, or occult blood in stool, endoscopy may become more of a priority.

How Does Biopsy Evaluate Gastric Cancer Risk?

Biopsy is the process of taking small samples from stomach tissue during endoscopy and examining them in the laboratory. Biopsy is of great importance in gastric cancer risk assessment because cellular changes in the gastric mucosa can only become clear with microscopic examination.

As a result of biopsy, some precursor conditions that may be associated with gastric cancer can be detected. Atrophic gastritis, intestinal metaplasia, and dysplasia are among these conditions. The presence of these findings may require closer follow-up of the person. However, not every biopsy finding means cancer. What matters is that the correct follow-up plan is created by the physician according to the degree and extent of the finding.

Biopsy can also help evaluate H. pylori infection. H. pylori is a bacterium that can cause long-term inflammation in the gastric mucosa and may increase the risk of gastric cancer in some people. Therefore, samples taken during endoscopy can provide important information in terms of both tissue changes and infection.

Why Are H. pylori Tests Important in Gastric Cancer Risk?

Helicobacter pylori is a bacterium that can settle in the stomach and cause long-term gastritis. H. pylori infection is quite common; however, it does not cause gastric cancer in everyone. Still, persistent infection may prepare the ground for changes such as chronic inflammation, atrophy, and intestinal metaplasia in the gastric mucosa in some people.

In the check-up process, H. pylori evaluation can be performed with different methods. H. pylori can be investigated by breath test, stool antigen test, blood test, or biopsy samples taken during endoscopy. Which method will be preferred is determined according to the person’s complaints, whether they have received treatment before, and the physician’s evaluation.

H. pylori positivity alone does not mean that there is gastric cancer. However, when infection is detected, treatment and then confirmation of eradication are important. Because successful clearance of the bacterium can help control the long-term inflammatory process in the gastric mucosa.

What Clues Can Blood Tests Give in Gastric Cancer Risk?

Blood tests are not tests that directly show gastric cancer. However, some blood tests performed during check-up may give clues that should be considered regarding the digestive system. Especially complete blood count, iron level, ferritin, vitamin B12, and inflammation markers can be interpreted together by the physician.

In gastric cancer or other stomach-related diseases, anemia due to chronic blood loss may be seen. This condition may especially appear as iron deficiency anemia. Unexplained anemia, especially in older age groups or together with gastrointestinal complaints, may require a more detailed evaluation in terms of the digestive system.

B12 deficiency may also be associated with some stomach diseases. Especially in conditions that affect the gastric mucosa, such as atrophic gastritis, B12 absorption may be impaired. Therefore, although blood tests do not show gastric cancer on their own, they provide important complementary information in stomach health and digestive system evaluation.

Does the Fecal Occult Blood Test Show Gastric Cancer Risk?

The fecal occult blood test helps evaluate whether there is unnoticed bleeding in the digestive system. Although this test is more commonly known for colorectal cancer screening, it can also be positive in bleeding originating from different parts of the digestive system. Stomach ulcer, gastritis, polyps, or some gastric tumors may cause bleeding.

However, a positive fecal occult blood test does not directly mean gastric cancer. The source of bleeding may be the stomach, intestine, hemorrhoids, or another condition. Therefore, a positive result must be evaluated by a physician. If necessary, further examinations such as endoscopy or colonoscopy may be planned.

A negative test does not mean that gastric cancer risk is completely eliminated. Because not every gastric cancer may bleed, or bleeding may not be continuous. Therefore, the fecal occult blood test is not a test that makes decisions on its own, but one of the supportive parts of the general risk assessment.

Are Tumor Markers Sufficient in Gastric Cancer Screening?

In some blood tests, values called tumor markers can be measured. However, these markers are not reliable on their own for gastric cancer screening. Tumor markers may also change in different diseases, inflammatory conditions, or other cancer types. They may also be normal in early-stage gastric cancer.

For this reason, normal tumor markers do not mean that there is no gastric cancer risk at all. Similarly, high levels do not directly diagnose cancer. Tumor markers may be meaningful mostly in special situations such as follow-up of the disease or evaluation of treatment response in some patients who have already been diagnosed.

It is not correct to give excessive meaning to tumor markers in order to evaluate gastric cancer risk during the check-up process. Complaints, risk factors, endoscopy findings, and biopsy results are much more decisive. Therefore, even if tumor markers are present, they should be addressed together with physician interpretation.

Who Are the People at Risk for Gastric Cancer?

When evaluating gastric cancer risk, the person’s entire health history should be taken into account. A family history of gastric cancer, H. pylori infection, chronic gastritis, atrophic gastritis, intestinal metaplasia, gastric polyps, previous stomach surgeries, and some genetic predispositions may increase the risk.

Lifestyle is also important in gastric cancer risk. Frequent consumption of very salty, smoked, or processed foods, smoking, excessive alcohol consumption, insufficient intake of vegetables and fruits, and long-term uncontrolled stomach complaints should be considered in risk assessment. These factors do not mean cancer on their own; however, they can affect the risk profile.

Especially if there is unexplained weight loss, loss of appetite, difficulty swallowing, early satiety, persistent stomach pain, recurrent vomiting, black stool, anemia, or a family history of gastric cancer, the check-up process should not be postponed. These symptoms can also be seen in many diseases other than gastric cancer; however, they definitely require specialist evaluation.

Should Everyone With Stomach Complaints Have Endoscopy?

Complaints such as stomach pain, indigestion, bloating, or reflux are very common. Most of these symptoms may occur due to benign causes. However, in some cases, these complaints need to be examined in more detail. The decision for endoscopy is made according to the duration and severity of the complaint, accompanying warning findings, and the person’s age.

In short-term and mild stomach complaints, lifestyle arrangements, dietary changes, or medication treatment with physician recommendation may first be planned. However, if the complaints last long, recur, or are accompanied by alarm symptoms, endoscopic evaluation may be required.

Alarm symptoms include unexplained weight loss, difficulty swallowing, bloody vomiting, black stool, persistent vomiting, anemia, and a family history of gastric cancer. If these symptoms are present, the person should not postpone the process by using medication on their own and should consult a gastroenterology specialist.

How Is Gastric Cancer Risk Interpreted in the Check-Up Process?

In the check-up process, gastric cancer risk is not interpreted according to a single test result. The physician evaluates the person’s complaints, age, family history, eating habits, smoking and alcohol use, laboratory results, and, if necessary, endoscopy findings together. This holistic evaluation ensures that unnecessary tests are avoided while risky conditions are not missed.

For example, the evaluation process of a young person who only has heartburn is not the same as that of an older person who has unexplained anemia and a family history of gastric cancer. Therefore, check-up should be planned individually. Standard packages may provide guidance; however, interpretation of the results by a specialist is critical for follow-up.

If findings such as H. pylori positivity, anemia, occult blood in stool, gastritis on endoscopy, or intestinal metaplasia on biopsy are detected as a result of the check-up, the follow-up plan is created according to these findings. While control after treatment may be sufficient in some people, endoscopic follow-up at certain intervals may be required in others.

Manage Your Check-Up Process for Digestive System Health With Happ Health

Gastric cancer risk assessment is not a process that can be completed only by looking at blood tests. Digestive system complaints, family history, presence of H. pylori, endoscopy findings, and biopsy results should be evaluated together. Happ Health, with its digital health platform structure, offers a solution that provides easier access to check-up and specialist evaluation processes. With the Digestive System Package, you can evaluate your stomach and intestinal health in a more planned way and manage the necessary steps more consciously by following your results together with specialist opinion.